We have two new exciting chemical biology/proteomics postdoc positions available in our group. If you're interested in drug target discovery at the interface between industry & academia please apply! Deadline 17th February 2022.
1: https://bit.ly/3rEcRe0 - Postdoctoral Scientist - Cancer Biology & Systems Pharmacology
2: https://bit.ly/3Ak6uAo - Oxford-BMS Postdoctoral Fellow – Chemical Biology & Proteomics
Congratulations to our friends at Promega & SGC-UNC who have developed a platform to comprehensively study CDK inhibitor target engagement across the whole family in live cells. Very excited we could contribute - check out the full paper now published in Nature Communications:
Congratulations to Jenny & Adan on their work on covalent inhibitors of DUBs now published in J. Med. Chem.
This has been a great collaboration between the labs of Ed Tate, Benedict Kessler, Olivier Feron, and the Huber group.
